SEC Form 4 · accession 0001127602-15-030535
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Eberly
Officer — EVP,Pres Meridian Life Science
Period of report
Nov 4, 2015
Accepted (ET)
Nov 6, 2015 · 12:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 4, 2015 | A | 10,000 | $0.00 | A | 52,719 | D | |
| Common StockF2 | Nov 4, 2015 | A | 10,000 | $0.00 | A | 62,719 | D | |
| Common StockF3 | Nov 5, 2015 | D | 9,000 | $0.00 | D | 53,719 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest in full (or 100%) on November 15, 2019.
- F2These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest 25% per year over four years, subject to attainment of a specified earnings target for fiscal 2016.
- F3These restricted stock units were awarded under the 2012 Stock Incentive Plan and were subject to attainment by the Company of a specified earnings target for fiscal 2015. As the Company did not reach the target, these restricted stock units have been cancelled.